CPC C07K 16/2818 (2013.01) [A61P 35/00 (2018.01); C07K 16/2827 (2013.01); C12N 15/1137 (2013.01); A61K 2039/505 (2013.01)] | 21 Claims |
1. A method of treating cancer in a patient, the method comprising:
administering to a patient in need thereof a therapeutically effective amount of a lysine-specific demethylase 1A (LSD1) inhibitor to thereby treat cancer in the patient, wherein the LSD1 inhibitor comprises an inhibitory nucleic acid comprising SEQ ID NO: 2.
|